CB-Lin 0.50 mg is a medication containing cabergoline, a dopamine agonist used primarily to treat hyperprolactinemia—an endocrine disorder characterized by abnormally high levels of prolactin in the blood. Excess prolactin can lead to irregular menstrual cycles, infertility, unwanted breast milk production, and decreased libido. By stimulating dopamine receptors in the pituitary gland, CB-Lin inhibits the secretion of prolactin, restoring hormonal balance and reducing associated symptoms. In higher doses, cabergoline is also prescribed for conditions like Cushing’s disease or to suppress lactation when breastfeeding is not recommended.
Your CB-Lin 0.50mg tablet is typically taken once or twice a week, depending on your doctor’s guidance, which is necessary to monitor prolactin levels and adjust dosage accordingly. Swallow the tablet whole with food to minimize stomach upset. Dose titration often starts low and gradually increases to achieve the desired therapeutic effect while limiting side effects. Never exceed the prescribed dose, and do not abruptly stop taking cabergoline without medical advice, as rebound prolactin levels may occur.
Common side effects may include nausea, vomiting, abdominal discomfort, constipation, dizziness, headaches, fatigue, and nasal congestion. Taking the medication at bedtime or with meals can help reduce gastrointestinal symptoms. Because cabergoline can lower blood pressure, some users may experience lightheadedness or fainting when standing up quickly; it’s important to move slowly and stay hydrated. Rarely, long-term use may affect heart valves, so periodic echocardiogram monitoring is recommended for patients on extended therapy.
CB-Lin 0.50 mg can interact with other dopamine agonists, antipsychotic medications, blood pressure medicines, or macrolide antibiotics. Inform your healthcare provider of all medications and supplements you are taking to avoid adverse interactions. Patients with severe liver disease, cardiovascular disease, or a history of pulmonary fibrosis should exercise caution and may require lower doses or alternative treatments. Cabergoline is contraindicated during pregnancy unless specifically recommended; women should discuss fertility and contraception options before starting therapy. Using CB-Lin 0.50mg responsibly under medical supervision can effectively manage prolactin-related disorders and improve quality of life.
Your CB-Lin 0.50mg tablet is typically taken once or twice a week, depending on your doctor’s guidance, which is necessary to monitor prolactin levels and adjust dosage accordingly. Swallow the tablet whole with food to minimize stomach upset. Dose titration often starts low and gradually increases to achieve the desired therapeutic effect while limiting side effects. Never exceed the prescribed dose, and do not abruptly stop taking cabergoline without medical advice, as rebound prolactin levels may occur.
Common side effects may include nausea, vomiting, abdominal discomfort, constipation, dizziness, headaches, fatigue, and nasal congestion. Taking the medication at bedtime or with meals can help reduce gastrointestinal symptoms. Because cabergoline can lower blood pressure, some users may experience lightheadedness or fainting when standing up quickly; it’s important to move slowly and stay hydrated. Rarely, long-term use may affect heart valves, so periodic echocardiogram monitoring is recommended for patients on extended therapy.
CB-Lin 0.50 mg can interact with other dopamine agonists, antipsychotic medications, blood pressure medicines, or macrolide antibiotics. Inform your healthcare provider of all medications and supplements you are taking to avoid adverse interactions. Patients with severe liver disease, cardiovascular disease, or a history of pulmonary fibrosis should exercise caution and may require lower doses or alternative treatments. Cabergoline is contraindicated during pregnancy unless specifically recommended; women should discuss fertility and contraception options before starting therapy. Using CB-Lin 0.50mg responsibly under medical supervision can effectively manage prolactin-related disorders and improve quality of life.
0